Received: 13 December 2021
Accepted: 15 March 2022
First Online: 24 March 2022
: The study was approved by the local ethics committee, the Ethikkommission Nordwest- und Zentralschweiz and need for individual informed consent was waived by the committee due to the retrospective design (ExternalRef removed; project-ID: 2020–02434). There was no patient or public involvement in the design, conduct, reporting or dissemination of this research. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: Gregor Lindner received honoraria from Bayer, Daiichi-Sankyo, Otsuka as well as travel grants from GSK, Pierre Fabré, Otsuka, Bayer. For the remaining authors none were declared.